Clinical Trial Update: Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of desloratadine in children with allergy sensitivity and chronic hives who are poor metabolizers of desloratadine; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopy
• Idiopathic Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Chronic Idiopathic Urticaria, Atopy | Phase 3 | Status: COMPLETED